🇺🇸

US SEC Filing Intelligence

· daily

VA Healthcare & Services Contracts — August 15, 2026

This digest covers a single, large civilian healthcare contract awarded by the Department of Veterans Affairs (VA) to TriWest Healthcare Alliance Corp valued at $798.7 million. With zero defense-related contracts in the period, the dominant theme is VA healthcare services procurement. The highest-conviction signal is neutral due to the contract's extremely short one-month performance period, which creates high revenue uncertainty despite the large headline value. A key risk is the $0 currently outlayed, indicating no executed funding, making the contract's material financial impact highly speculative until follow-on obligations or extensions are announced.

1 total filings
· daily

New Federal Contractors — August 15, 2026

The three contracts analyzed total $896.3 million in obligations, but the aggregate is overwhelmingly driven by a single $798.7 million, one-month firm-fixed-price delivery order to TriWest Healthcare Alliance Corp from the Department of Veterans Affairs. Only one of the three contracts is defense-related—a $1.5 million Lockheed Martin task order from the U.S. Coast Guard—making this a civilian-heavy procurement snapshot with a healthcare insurance focus rather than a pure defense signal. The highest-conviction signal is the extreme revenue concentration and short performance period of the TriWest award, which creates ambiguity about recurring revenue. A critical risk is that zero dollars have been outlaid on the TriWest contract, coupled with a five-year-old SBIR/STTR award to Chesapeake Technology International from the GSA that lacks any financial or performance detail, materially weakening the actionable signal quality across the digest.

3 total filings
· daily

Significant Contract Modifications ($10M+) — August 15, 2026

The three contracts analyzed total $896.3 million in obligations, with only one-third defense-related and a dominant civilian theme led by the Department of Veterans Affairs' $798.7 million award to TriWest Healthcare Alliance Corp for direct health insurance services. The aggregate signal strength is low (3.7/10), reflecting limited actionable conviction. The highest-conviction signal is the VA's short-duration, fixed-price delivery order to TriWest, which suggests a potential transitional or pilot arrangement but carries execution risk due to its one-month performance period and zero outlays. A key watch item is whether TriWest secures follow-on awards or extensions, as the contract's annualized revenue rate implies over $9.6 billion if sustained monthly.

3 total filings
· daily

Contract Deobligations Alert — August 15, 2026

The three contracts analyzed total $896.3 million in obligations, with a heavy civilian tilt (99.8% civilian, 0.2% defense-related). The dominant theme is a massive, short-duration $798.7 million VA healthcare insurance award to TriWest Healthcare Alliance Corp, which carries high uncertainty due to zero outlays and a one-month performance period. A small $1.5 million Lockheed Martin Coast Guard IT maintenance contract reinforces incumbency but is immaterial. The highest-conviction signal is the TriWest contract's potential to indicate a transitional VA procurement strategy, but the lack of exercised options and outlays presents a key risk for revenue recognition.

3 total filings
· daily

Contract Option Exercises — August 15, 2026

The three contracts analyzed from August 15, 2026 total $896.3 million in obligations, with a striking 89% concentration in a single, short-duration civilian healthcare award to TriWest Healthcare Alliance Corp ($798.7M) from the Department of Veterans Affairs, which heavily skews the aggregate value but carries high execution risk due to its one-month performance period and zero outlays. Only one contract is defense-related—a $1.5 million non-competitive Lockheed Martin task order from the U.S. Coast Guard for IT maintenance, reinforcing a niche incumbent position but with negligible financial impact. The highest-conviction signal is the VA’s potential pilot or transitional healthcare spending, while the key risk is the TriWest contract’s uncertain follow-on and the $0 outlayed status, which could indicate delayed or non-performance. Overall, this digest offers limited actionable investment signals due to low materiality and neutral signals across all three awards.

3 total filings
· daily

Mega Contracts Monitor ($100M+) — August 15, 2026

The sole contract in this period is a $798.7 million firm-fixed-price delivery order from the Department of Veterans Affairs to TriWest Healthcare Alliance Corp for direct health and medical insurance services. This is a civilian award with no defense-related content, and the extremely short one-month performance period (July 2026) with zero outlays to date creates significant uncertainty about revenue recognition and contract durability. The neutral signal strength (3/10) and medium materiality (5/10) reflect the large headline value but ambiguous execution timeline. Key watch items include any follow-on obligations or extensions that would indicate recurring revenue, and the broader VA procurement trend in health insurance administration.

1 total filings
· daily

High-Value Federal Grants ($5M+) — August 15, 2026

This digest covers two civilian-agency contracts totaling $894.8 million, with zero defense-related awards, indicating a purely civilian sector focus. The dominant signal is a massive $798.7 million firm-fixed-price delivery order from the Department of Veterans Affairs to TriWest Healthcare Alliance Corp, but its extremely short one-month performance period and zero outlays create high uncertainty about revenue recognition and program continuity. A second, smaller $96.1 million SBIR/STTR award to Chesapeake Technology International Corp from the GSA lacks sufficient detail for material analysis. The highest-conviction signal is neutral: TriWest’s contract suggests a transitional or pilot healthcare arrangement for veterans, but the lack of exercised options and the compressed timeline pose execution and budget risks. Key watch items include any follow-on obligations for TriWest and the resolution of the VA’s healthcare procurement strategy.

2 total filings
· daily

General Federal Contracts — August 15, 2026

The August 15, 2026 digest reveals $894.8 million in total obligations, entirely from civilian agencies (0% defense-related), signaling a near-term surge in non-DOD healthcare spending. The dominant signal is a massive, $798.7 million one-month firm-fixed-price delivery order awarded to TriWest Healthcare Alliance Corp by the Department of Veterans Affairs, which carries high revenue concentration risk and execution uncertainty due to its compressed timeline. A second, smaller $96.1 million SBIR/STTR award to Chesapeake Technology International from the GSA provides negligible near-term revenue visibility. The highest-conviction signal is the VA's apparent shift toward short-duration, high-value health insurance contracts, which may indicate a transitional procurement strategy. The key risk is that the TriWest contract has zero outlays to date, meaning the entire $798.7 million obligation is contingent on successful execution within a single month, creating a binary outcome for the contractor.

2 total filings
· daily

DHS Homeland Security Contracts — August 14, 2026

Over the analyzed period, the Department of Homeland Security (DHS) awarded $223.7 million in contracts, with zero defense-related spending, underscoring a purely civilian procurement focus. The dominant signal is a $215.5 million non-competitive, firm-fixed-price award to Eastern Air Express LLC for ICE aircraft operations, representing 96% of total obligation and highlighting a high-concentration risk in a single, small disadvantaged business. A second, immaterial $8.18 million task order to Lockheed Martin for Coast Guard software maintenance confirms stable but low-growth IT sustainment spending. The highest-conviction signal is neutral: Eastern Air Express’s award offers near-term revenue visibility but lacks competitive market validation, posing execution and pricing risk. Key watch items include option exercise by February 2028 and potential protests against the sole-source award.

2 total filings
· daily

VA Healthcare & Services Contracts — August 14, 2026

This digest covers a single, large civilian contract from the Department of Veterans Affairs (VA) to Oracle Health Government Services, Inc., valued at $114.35 million. The award is a firm-fixed-price delivery order for the VA's Electronic Health Record Modernization (EHRM) program, representing a stable, multi-year revenue stream for Oracle. The highest-conviction signal is bullish, driven by the contract's long duration (4 years) and alignment with a top federal IT priority. However, the non-competitive, sole-source nature of the award introduces a key risk regarding potential protests and a lack of competitive validation for the pricing.

1 total filings
· daily

New Federal Contractors — August 14, 2026

This digest covers three federal contracts totaling $338.1 million, all from civilian agencies (0% defense-related), with an average signal strength of 5.3/10. The dominant theme is Department of Homeland Security (DHS) spending, accounting for $223.7 million across two awards, while the Department of Veterans Affairs (VA) contributes $114.4 million. The highest-conviction signal is a bullish, multi-year $114.4 million Oracle Health Government Services VA IT contract, offering stable revenue visibility through 2027. A key risk is the $215.5 million Eastern Air Express DHS contract, awarded non-competitively to a small disadvantaged business, raising concerns about pricing discipline and competitive validation, with options extending to 2028.

3 total filings
· daily

Biotech Small-Cap Approvals — August 14, 2026

The August 14, 2026 approval digest is dominated by 8 generic/biosimilar approvals, with zero NMEs, zero label expansions, and zero biosimilars (as defined by the data provider, though all are categorized as 'FALLBACK' type). The period lacks any high-value first-in-class or breakthrough therapy catalysts, resulting in a uniformly neutral signal across all events. The dominant theme is the continued commoditization of established small-molecule and contrast-agent markets, with Aurobindo Pharma receiving three approvals (triamcinolone acetonide, brivaracetam, vancomycin hydrochloride) and Lupin, Novitium Pharma, Huaren Pharmaceutical, Viwit Pharm, and Macleods Pharma each receiving one. The highest-conviction signal is the absence of any NME or priority review approval, which suggests a quiet period for small-cap biotech catalysts and reinforces a defensive, non-event-driven stance for the sector. The key risk is the lack of commercial differentiation among these approvals, offering limited pricing power and no new therapeutic options for investors to underwrite.

8 total filings
· daily

Significant Contract Modifications ($10M+) — August 14, 2026

The three contracts analyzed total $338.1 million in obligations, all from civilian agencies (0% defense-related), with the Department of Homeland Security (DHS) dominating via a $215.5 million award to Eastern Air Express LLC for ICE operational support. The highest-conviction signal is Oracle Health Government Services' $114.4 million VA EHRM contract, which offers stable multi-year revenue through 2027. Key risk: Eastern Air Express's sole-source, non-competed award raises pricing and protest vulnerability concerns, while Lockheed Martin's $8.2 million Coast Guard task order is immaterial for the defense prime. Overall, the digest highlights civilian agency IT and operational spending stability, but with limited competitive validation and no defense exposure.

3 total filings
· daily

New Drug Approvals (Original) — August 14, 2026

The August 14, 2026 FDA approval stream is entirely composed of 8 biosimilar (FALLBACK) approvals, with zero NMEs, zero label expansions, and zero Breakthrough or Priority Review designations. This period reflects a pure generics/biosimilar wave, dominated by established molecules such as FOSFOMYCIN TROMETHAMINE (NOVITIUM PHARMA), VALSARTAN (HUAREN PHARMACEUTICAL CO LTD), and BRIVARACETAM (AUROBINDO PHARMA). The highest-conviction signal is AUROBINDO PHARMA’s three separate biosimilar approvals (TRIAMCINOLONE ACETONIDE, BRIVARACETAM, VANCOMYCIN HYDROCHLORIDE), signaling strong execution capability in the generics space. The key risk is the absence of any novel therapeutic innovation, which may disappoint investors seeking high-growth NME catalysts, and the potential for accelerated price erosion in already crowded markets like valsartan and vancomycin.

8 total filings
· daily

Contract Deobligations Alert — August 14, 2026

The three contracts analyzed total $338.1 million in obligations, all from civilian agencies (0% defense), with the Department of Homeland Security (DHS) as the dominant spender across two awards. The highest-conviction signal is Oracle Health Government Services' $114.4 million sole-source VA EHRM contract, a multi-year bullish indicator for federal IT modernization. However, the largest award—$215.5 million to Eastern Air Express LLC for ICE operational support—carries execution risk due to its non-competitive, firm-fixed-price structure and reliance on option exercises. Key risk: the non-competitive nature of both the Eastern Air Express and Oracle awards limits market validation and raises protest vulnerability.

3 total filings
· daily

Contract Option Exercises — August 14, 2026

This digest covers $338.1 million in total obligations across three civilian agency contract actions announced in August 2026, with zero defense-related awards. The dominant theme is Department of Homeland Security (DHS) spending on aviation support and critical infrastructure IT maintenance, led by a $215.5 million sole-source award to Eastern Air Express LLC for ICE aircraft operations—a material revenue stream for a small, disadvantaged business. The highest-conviction signal is Oracle Health Government Services’ $114.4 million non-competed VA EHRM support contract, which provides multi-year revenue stability for Oracle in a priority IT modernization area through 2027. Key risks include the lack of competitive validation on two of three awards and fixed-price margin pressure on Eastern Air Express. Investors should watch option exercises on Eastern Air Express’s contract as a catalyst for further revenue visibility.

3 total filings
· daily

Federal IT & Cybersecurity Contracts — August 14, 2026

This digest covers a single, high-value civilian contract: a $114.35 million firm-fixed-price delivery order from the Department of Veterans Affairs to Oracle Health Government Services, Inc. for its EHRM Forward Deployed Solution Set. The contract is entirely civilian, with no defense exposure, and underscores the VA's ongoing IT modernization push. The highest-conviction signal is Oracle's multi-year revenue visibility through 2027, though the non-competitive award structure introduces execution and protest risk. Key watch items include option exercises and potential legal challenges to the sole-source nature of the award.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — August 14, 2026

The two contracts analyzed total $329.9 million in obligations, with zero defense-related awards, underscoring a purely civilian procurement focus. The dominant theme is DHS/ICE operational support via a $215.5 million sole-source award to Eastern Air Express LLC, which carries medium pricing risk and limited competitive validation. The second contract is a $114.4 million multi-year VA IT award to Oracle Health Government Services, providing stable revenue visibility through 2027 but with non-competitive dynamics. The highest-conviction signal is Oracle's bullish, low-risk VA contract, while the key risk is Eastern Air Express's sole-source structure and potential for protest or margin pressure under firm-fixed-price terms.

2 total filings
· daily

General Federal Contracts — August 14, 2026

The three contracts total $338.1 million in obligations, all from civilian agencies (DHS/ICE, VA, and USCG), with zero defense-related awards, underscoring a civilian-led procurement theme. The dominant sector is government services and IT modernization, led by a $215.5 million ICE air transport contract to Eastern Air Express and a $114.4 million VA EHRM delivery order to Oracle Health. The highest-conviction signal is Oracle's multi-year, non-competed VA contract, which provides stable revenue visibility through 2027 and aligns with federal IT modernization priorities. Key risks include the non-competitive nature of two of the three awards (Eastern Air Express and Oracle), which raises pricing and protest concerns, and the relatively small Lockheed Martin task order that is immaterial to its overall revenue. Watch for option exercises on the Eastern Air Express contract (potential $327.9 million total) and any protests on the Oracle award, as these could impact revenue certainty.

3 total filings